1-3 of 3
Ming S. Lee
Close
Sort by
Journal Articles

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Clinical Trials & Observations
Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Chitra Hosing, Martin Korbling, Ming S. Lee, L. Jeffrey Medeiros, Luis Fayad, Felipe Samaniego, Amin Alousi, Paolo Anderlini, Daniel Couriel, Marcos de Lima, Sergio Giralt, Sattva S. Neelapu, Naoto T. Ueno, Barry I. Samuels, Fredrick Hagemeister, Larry W. Kwak, Richard E. Champlin
Journal: Blood
Blood (2008) 111 (12): 5530–5536.
https://doi.org/10.1182/blood-2008-01-136242
Published: 2008
Journal Articles

Nonmyeloablative Allogeneic Transplantation (NMT) for Relapsed Follicular Lymphoma (FL): Continuous Complete Remission with Longer Follow-Up.

Issa F. Khouri, MD, Rima M. Saliba, PhD, Martin Korbling, MD, Chitra Hosing, MD, Luis Fayad, MD, Ming S. Lee, MD, Felipe Samaniego, MD, Barry I. Samuels, MD, Daniel Couriel, MD, Fredrick Hagemeister, MD, Peter McLaughlin, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2007) 110 (11): 485.
https://doi.org/10.1182/blood.V110.11.485.485
Published: 2007
Journal Articles

ZAP-70 Status Does Not Predict Outcome after Nonmyeloablative Allogeneic Stem-Cell Transplantation (NST) in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) That Fails To Respond to Conventional Chemoimmunotherapy.

Issa F. Khouri, MD, Rima M. Saliba, PHD, Joan Admirand, MD, Susan O’Brien, MD, Ming-S. Lee, MD, Barry I. Samuels, MD, Sergio Giralt, MD, Marcos de Lima, MD, Michael J. Keating, MD, Richard E. Champlin, MD, Carlos Bueso-Ramos, MD
Journal: Blood
Blood (2006) 108 (11): 3028.
https://doi.org/10.1182/blood.V108.11.3028.3028
Published: 2006